NSCLC with STK11 and/or KEAP1 mutations represents one of most aggressive types of cancer, characterized by resistance to standard cytotoxic chemotherapy or radiotherapy (20, 25–27). The gene discussed is STK11; the disease is non-small cell lung carcinoma.